Turning to the company's dividend, Knauss reiterated that Clorox is committed to both its dividend and its share-repurchase program as well as continuing to support its growth through reinvestment. He said the company's health and wellness strategy continues to do well as Clorox expands more into the commercial market at facilities including hospitals and acute-care facilities.
Cramer continued his support for Clorox.
Executive Decision: Larry Young
In his third "Executive Decision" segment, Cramer sat down with Larry Young, president and CEO of Dr Pepper Snapple Group (DPS - Get Report), a stock that's just off its 52-week high after delivering a seven-cents-a-share earnings beat. Shares of Dr Pepper currently yield over 3%.Young said that the key to Dr Pepper's success has been new products, which is why the company is seeing growth in its carbonated and non-carbonated businesses. These new products have also helped Dr Pepper respond to criticism over sugary drinks because they give consumers more choices. When asked about the company's strategy, Young said his goal is to make Dr Pepper the best drink company out there, which is why it continues to focus mainly on North America and not overseas growth, and why the focus is on soft drinks and not snack foods or other categories. Dr Pepper had its IPO at the worst possible time five years ago, noted Young. Yet, despite the downturn, the company has built a fabulous team and reinvented itself to great success. Dr Pepper is also responding to changing tastes, said Young. For instance, the company has reformulated Hawaiian Punch to remove much of the sugar and replace it with vitamins. Cramer remained bullish on Dr Pepper.